Bangalore-based Anthem Biosciences has raised ₹1,016.02 crore from 60 anchor investors before its Initial Public Offering (IPO).
The anchor investor portion of the IPO opened on 11th July. For retail investors, the IPO will be available from 14th July and will close on 16th July.
The company has allotted 1.78 crore shares to anchor investors at the top price of ₹570 per share.
IPO Price, Size, and Share Allocation
The IPO price band is set between ₹540 and ₹570 per share. Investors must buy at least one lot, which contains 26 shares, meaning the minimum investment is ₹14,820.
Employees of Anthem Biosciences will get a ₹50 discount on each share.
The IPO is a mainboard listing and will be listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
The total IPO size is ₹3,395 crore, with 5.96 crore shares being sold. This is an offer-for-sale, so no new shares are being issued by the company.
The shares are divided as follows:
50% for Qualified Institutional Buyers (QIBs)
15% for Non-Institutional Investors (NIIs)
35% for Retail Investors
According to InvestorsGain, the IPO is currently trading at a grey market premium (GMP) of ₹86 per share. The highest GMP recorded so far is ₹103 per share.
